Courtney DiNardo, MD, on Study Methods Evaluating a Doublet, Triplet Regimens in AML
July 8th 2020At the 2020 ASCO Virtual Program, Courtney DiNardo, MD, presented on a study of the combination therapy consisting of ivosenidib plus venetoclax with or without azacytidine patients with IDH1-mutated acute myeloid leukemia.